Almaject Information

Almaject is focused on the development, acquisition, and commercialization of injectable generic pharmaceutical products. The current portfolio of injectables covers a broad range of therapeutic areas. Our commercial, business development, and R&D teams are creating new opportunities to expand our portfolio into complex molecules. Almaject Inc. is a US subsidiary of Alvogen. The parent company Alvogen, is a global, privately owned pharmaceutical company focused on the development, manufacturing and commercialization of generic, brand, OTC and biosimilar products around the world. Alvogen has commercial operations in 35 countries and operates four manufacturing and development hubs in the U.S., Romania, Korea and Taiwan.